Efficacy and safety of long-term (>7 year) alemtuzumab therapy for refractory T-cell large granular lymphocytic leukaemia

Horatiu Olteanu, Alexandra M. Harrington, Sarah Ramirez, Steven H. Kroft, Parameswaran Hari

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety of long-term (>7 year) alemtuzumab therapy for refractory T-cell large granular lymphocytic leukaemia'. Together they form a unique fingerprint.